A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

NCT03966898 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: SHR6390 Tablets
DRUG: Placebo Tablets
DRUG: Letrozole or Anastrozole Tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.